Racial disparities in pathological complete response among patients receiving neoadjuvant chemotherapy for early-stage breast cancer
F Zhao, M Miyashita, M Hattori, T Yoshimatsu… - JAMA network …, 2023 - jamanetwork.com
Importance Among patients with breast cancer, inconsistent findings have been published
on racial disparities in achieving pathologic complete response (pCR) after neoadjuvant
chemotherapy (NACT). Objective To investigate whether racial disparities exist in achieving
pCR and what factors contribute to them. Design, Setting, and Participants Within the
ongoing Chicago Multiethnic Epidemiologic Breast Cancer Cohort (ChiMEC), which consists
of a prospectively ascertained cohort of patients with breast cancer, 690 patients with stage I …
on racial disparities in achieving pathologic complete response (pCR) after neoadjuvant
chemotherapy (NACT). Objective To investigate whether racial disparities exist in achieving
pCR and what factors contribute to them. Design, Setting, and Participants Within the
ongoing Chicago Multiethnic Epidemiologic Breast Cancer Cohort (ChiMEC), which consists
of a prospectively ascertained cohort of patients with breast cancer, 690 patients with stage I …
以上显示的是最相近的搜索结果。 查看全部搜索结果